SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES, S.A.S.
Patent Owner
Stats
- 11 US PATENTS IN FORCE
- 1 US APPLICATIONS PENDING
- Oct 28, 2014 most recent publication
Details
- 11 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 1,586 Total Citation Count
- Nov 24, 1978 Earliest Filing
- 121 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
8871706 Method for inhibiting inflammation and pre-inflammatory cytokine/chemokine expression using a ghrelin analogueAug 07, 08Oct 28, 14[A61K]
8404804 Methods and intermediates for chemical synthesis of polypeptides and proteinsAug 27, 08Mar 26, 13[C07K]
7815928 Device for local administration of solid or semi-solid formulations and delayed-release formulations for proposal parenteral administration and preparation processAug 17, 07Oct 19, 10[A61F]
6349850 Method for preparing an injectable preparation and device for implementing sameFeb 18, 99Feb 26, 02[A61J]
6142972 Method and apparatus for the delivery of elongate solid drug compositionsJul 07, 98Nov 07, 00[A61F, A61M]
5958903 Galanthamine derivatives, and their pharmaceutical compositionsJan 09, 98Sep 28, 99[A61K, A01N, C07D]
5837276 Apparatus for the delivery of elongate solid drug compositionsSep 02, 94Nov 17, 98[A61K, B65D]
5462926 Neuromedin B receptor antagonists which demonstrate selectivityJun 17, 93Oct 31, 95[A61K, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2010/0227,806 Use Of A Ghrelin Agonist To Improve Catabolic Effects Of Glucocorticoid TreatmentAbandonedMar 09, 07Sep 09, 10[A61K, A61P]
2010/0204,449 METHODS AND INTERMEDIATES FOR CHEMICAL SYNTHESIS OF POLYPEPTIDES AND PROTEINSAbandonedAug 28, 08Aug 12, 10[C07C, C07K]
2010/0173,834 CYCLIC PEPTIDE MELANOCORTIN RECEPTOR LIGANDSAbandonedJun 13, 08Jul 08, 10[A61K, A61P, C07K]
2010/0144,714 DERIVATIVES OF IMIDAZO PYRIMIDO AND DIAZEPINE PYRIMIDINE-DIONE, AND USE THEREOF AS A DRUGAbandonedDec 17, 07Jun 10, 10[A61K, C07D, A61P]
7495009 Imidazopyridine derivatives as melancortin receptor agonistsExpiredMar 29, 04Feb 24, 09[A61K, C07D]
7494969 Heterocarpine, a plant-derived protein with anti-cancer propertiesExpiredAug 25, 03Feb 24, 09[A61K, A01N, A23J, C07K]
7495021 Benzothiazole- and benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitorsExpiredAug 31, 07Feb 24, 09[A61K, C07D]
2009/0023,780 Therapeutic use of a derivative of thienylcyclohexylamineAbandonedJul 16, 08Jan 22, 09[A61K, A61P]
7473779 Derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing themExpiredSep 12, 03Jan 06, 09[A61K, A01N, C07D, C07C]
7465721 2-hydroxytetrahydrofuran derivatives and use thereof as medicamentsExpiredDec 08, 04Dec 16, 08[C07D]
7459558 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing themExpiredApr 13, 05Dec 02, 08[C07D]
7445612 Safety injection device for a liquid or semi-solid compositionExpiredApr 10, 01Nov 04, 08[A61M]
2008/0108,683 4-PHENYLTHIAZOLE AND 4-PHENYLIMIDIZOLE DERIVATIVES AND THEIR USE AS MEDICAMENTS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES, PAIN AND EPILEPSYAbandonedOct 30, 07May 08, 08[A61K, C07D, A61P]
2008/0020,974 SOMATOSTATIN AND SOMATOSTATIN AGONISTS FOR TREATING INSULIN INSENSITIVITY AND SYNDROME XAbandonedAug 02, 07Jan 24, 08[A61K, A61P]
2007/0265,208 Association of calpain inhibitors and reactive oxygen species trapping agentsAbandonedJun 01, 07Nov 15, 07[A61K, A61P]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.